These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9680868)

  • 1. Heartburn: common but not trivial.
    Johns Hopkins Med Lett Health After 50; 1998 Aug; 10(6):6-7. PubMed ID: 9680868
    [No Abstract]   [Full Text] [Related]  

  • 2. Do you really need that heartburn med?
    Johns Hopkins Med Lett Health After 50; 2010 Sep; 22(7):4-5. PubMed ID: 20848752
    [No Abstract]   [Full Text] [Related]  

  • 3. Gastroesophageal reflux disease and a HAPPI quality of life.
    Johnston BT
    Am J Gastroenterol; 1999 Jul; 94(7):1723-4. PubMed ID: 10406226
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of gastroesophageal reflux disease: to step or not to step.
    McGuigan JE
    Am J Gastroenterol; 2001 Jun; 96(6):1679-81. PubMed ID: 11419813
    [No Abstract]   [Full Text] [Related]  

  • 5. Cisapride for nocturnal heartburn.
    Med Lett Drugs Ther; 1994 Feb; 36(915):11-3. PubMed ID: 8283956
    [No Abstract]   [Full Text] [Related]  

  • 6. [A common disease: heartburn. Self-medication with low-dose H2-receptor antagonists].
    Internist (Berl); 1998 Nov; 39(11 Suppl Selbstmedi):1-4. PubMed ID: 9844840
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of intermittent reflux symptoms: one size does not fit all.
    DeVault KR
    J Clin Gastroenterol; 2007 Jul; 41(6):546-7. PubMed ID: 17577109
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heartburn. Only a harmless symptom?].
    MMW Fortschr Med; 2001 Mar; 143(10):45. PubMed ID: 11277116
    [No Abstract]   [Full Text] [Related]  

  • 9. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
    Lee KJ; Kwon HC; Cheong JY; Cho SW
    Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical management of heartburn.
    Br Med J; 1974 Oct; 4(5936):64-5. PubMed ID: 4414623
    [No Abstract]   [Full Text] [Related]  

  • 11. [Proton pump inhibitors according to need. Always for heartburn].
    Labenz J
    MMW Fortschr Med; 2002 Jun; 144(23):34-7. PubMed ID: 12119901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonerosive reflux disease.
    Waring JP
    Semin Gastrointest Dis; 2001 Jan; 12(1):33-7. PubMed ID: 11215854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Step-down from multiple- to single-dose proton pump inhibitors (PPIs): a prospective study of patients with heartburn or acid regurgitation completely relieved with PPIs.
    Inadomi JM; McIntyre L; Bernard L; Fendrick AM
    Am J Gastroenterol; 2003 Sep; 98(9):1940-4. PubMed ID: 14499769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quigel: a new concept of gastric antacid and antireflux agent].
    Bianchi PG
    Minerva Dietol Gastroenterol; 1979; 25(4):455-6. PubMed ID: 554037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Dyspepsia and heartburn in primary care: a rational and economic approach].
    Labenz J
    MMW Fortschr Med; 2009 Aug; 151(34-35):47-8. PubMed ID: 19771792
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional heartburn and non-erosive reflux disease.
    Savarino V; Savarino E; Parodi A; Dulbecco P
    Dig Dis; 2007; 25(3):172-4. PubMed ID: 17827934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High- versus standard-dose ranitidine for control of heartburn in poorly responsive acid reflux disease: a prospective, controlled trial.
    Kahrilas PJ; Fennerty MB; Joelsson B
    Am J Gastroenterol; 1999 Jan; 94(1):92-7. PubMed ID: 9934737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heartburn severity does not predict disease severity in patients with erosive esophagitis.
    Fennerty MB; Johnson DA
    MedGenMed; 2006 Apr; 8(2):6. PubMed ID: 16926745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.
    Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB
    Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
    Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN
    Digestion; 2008; 77(2):69-72. PubMed ID: 18349541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.